Basel Metropolitan Area
🌟 Passionate Clinical Trial Leader and Project Management Expert 🌟 With nearly two decades of experience in leading international study teams and managing clinical trials across diverse therapeutic areas, I bring a wealth of expertise in project management, drug development processes, and clinical trial life cycles. 🚀 My journey has been enriched by postgraduate qualifications in management and certifications in Agile and Project Management from Google, shaping me into a versatile professional with a deep understanding of both scientific principles and organizational dynamics. 💼 Throughout my career, I have honed my skills in team leadership, guiding clinical trial managers to success through effective coaching and development. 🤝 My commitment to excellence is evident in my track record of leading key clinical trial projects with strict adherence to budgetary constraints and quality standards. 📊 Moreover, I am passionate about fostering operational excellence through continuous process improvement and knowledge sharing initiatives. By leveraging my extensive experience, I strive to drive impactful changes that optimize efficiency and drive success in every project I undertake. 🌟 Let's connect and explore opportunities to collaborate on innovative projects that push the boundaries of clinical research and healthcare advancement! 🌍💉
After a personal sabbatical period during which I supported my late father through his final months, I am now leading a new chapter of community-focused work through the Denis Asuagbor Association (DAA). Although the Association carries the name of the late Denis Asuagbor — remembered for integrity, discipline, and service — his passing was not cancer-related. The work we do reflects the values he lived by: standing with people during difficult moments and strengthening community care. DAA is a community health initiative dedicated to: • Cancer awareness and early detection education • Patient navigation support • Community outreach in underserved populations • Health education campaigns in local markets and communities In 2025, we conducted colon cancer and cervical cancer awareness campaigns in Buea, reaching community members directly in market settings and collecting valuable field data to better understand awareness gaps and barriers to screening. The focus now is to expand structured patient navigation and strengthen partnerships with health institutions to improve access to care.
Stepped away temporarily from professional activities to assume primary caregiving responsibilities for my father during a critical health period. This experience deepened my perspective on patient journeys, family support systems, and the importance of accessible health navigation — insights now guiding my community health engagement work.
• Coached Study Leaders and Clinical Trial Teams (CTTs) at Novartis in embracing innovative working methodologies. • Guided Study Leaders through the comprehensive development of CTT backlogs, enhancing project management efficiency. • Advised CTTs on establishing a productive working rhythm, including the implementation of time-boxing techniques for optimized performance. • Supported Study Leaders and Sub-Team Leaders in effectively facilitating CTT Sprints, Reviews, and Retro meetings, significantly improving team collaboration and project outcomes.
• Key member of the CTT transition workstream under the GCO Ambition initiative, driving transformative change and strategic alignment across teams. • Served as the Product Owner for the CTT Transition Guidebook, orchestrating collaboration with diverse line functions and SMEs to curate and align content, ensuring its comprehensive integration before implementation. • Masterminded the creation and deployment of the CTT Transition Guidebook, setting a new standard for transition excellence and operational guidance.
• Executed trial and related activities on time, within budget, and in adherence to high-quality standards, ensuring efficiency and quality. • Implemented proactive operational planning, including effective contingency and risk mitigation strategies. • Analyzed medical and operational feasibility for studies, providing crucial input and reviewing outcomes to enhance study design and implementation. • Drove initiatives that significantly increased patient enrollment across studies, demonstrating leadership in patient engagement strategies. • Managed budgets and resources cost-effectively, minimizing unforeseen cost overruns through meticulous financial oversight. • Achieved key milestones, including leading the setup and first patient enrollment for critical trials and contributing to scientific reviews and program activities, showcasing leadership in complex clinical trial environments.
Responsible for providing operational expertise and leadership of a Phase IIIb evaluating the effectiveness, safety, and tolerability of tapentadol PR in subjects with severe chronic cancer-related pain due to solid tumors
Overall trial management responsibility of a phase 2 GLP-1 once weekly trial.
Responsible for overall clinical study management of a phase II trial for a once weekly GLP-1 analog